Annual CFF
$75.98 M
+$74.89 M+6838.81%
December 31, 2023
Summary
- As of February 7, 2025, IKNA annual cash flow from financing activities is $75.98 million, with the most recent change of +$74.89 million (+6838.81%) on December 31, 2023.
- During the last 3 years, IKNA annual CFF has fallen by -$40.20 million (-34.60%).
- IKNA annual CFF is now -42.32% below its all-time high of $131.74 million, reached on December 31, 2021.
Performance
IKNA Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFF
$0.00
$0.000.00%
September 30, 2024
Summary
- As of February 7, 2025, IKNA quarterly cash flow from financing activities is $0.00, unchanged on September 30, 2024.
- Over the past year, IKNA quarterly CFF has dropped by -$38.92 million (-100.00%).
- IKNA quarterly CFF is now -100.00% below its all-time high of $132.53 million, reached on March 31, 2021.
Performance
IKNA Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFF
$60.00 K
-$38.92 M-99.85%
September 30, 2024
Summary
- As of February 7, 2025, IKNA TTM cash flow from financing activities is $60.00 thousand, with the most recent change of -$38.92 million (-99.85%) on September 30, 2024.
- Over the past year, IKNA TTM CFF has dropped by -$75.86 million (-99.92%).
- IKNA TTM CFF is now -99.98% below its all-time high of $248.69 million, reached on March 31, 2021.
Performance
IKNA TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
IKNA Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +6838.8% | -100.0% | -99.9% |
| 3 y3 years | -34.6% | -100.0% | -99.8% |
| 5 y5 years | +365.7% | -100.0% | -99.8% |
IKNA Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -42.3% | +6838.8% | -100.0% | at low | -100.0% | +120.3% |
| 5 y | 5-year | -42.3% | +6838.8% | -100.0% | +100.0% | -100.0% | +120.3% |
| alltime | all time | -42.3% | +6838.8% | -100.0% | +100.0% | -100.0% | +120.3% |
Ikena Oncology Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $0.00(0.0%) | $60.00 K(-99.8%) |
| Jun 2024 | - | $0.00(-100.0%) | $38.98 M(-48.7%) |
| Dec 2023 | $75.98 M(+6838.8%) | $60.00 K(-99.8%) | $75.98 M(+0.1%) |
| Sep 2023 | - | $38.92 M(+5.2%) | $75.92 M(+105.0%) |
| Jun 2023 | - | $37.00 M(>+9900.0%) | $37.03 M(+3281.5%) |
| Dec 2022 | $1.09 M(-99.2%) | $1000.00(-95.8%) | $1.09 M(-17.7%) |
| Sep 2022 | - | $24.00 K(-95.8%) | $1.33 M(-3.3%) |
| Jun 2022 | - | $575.00 K(+16.2%) | $1.38 M(-566.1%) |
| Mar 2022 | - | $495.00 K(+109.7%) | -$295.00 K(-100.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | $131.74 M(+13.4%) | $236.00 K(+242.0%) | $131.74 M(-46.8%) |
| Sep 2021 | - | $69.00 K(-106.3%) | $247.66 M(+0.0%) |
| Jun 2021 | - | -$1.09 M(-100.8%) | $247.60 M(-0.4%) |
| Mar 2021 | - | $132.53 M(+14.1%) | $248.69 M(+114.0%) |
| Dec 2020 | $116.18 M(+612.1%) | $116.16 M(>+9900.0%) | $116.18 M(>+9900.0%) |
| Sep 2020 | - | $0.00(0.0%) | $21.00 K(0.0%) |
| Jun 2020 | - | $0.00(-100.0%) | $21.00 K(0.0%) |
| Mar 2020 | - | $21.00 K | $21.00 K |
| Dec 2019 | $16.32 M | - | - |
FAQ
- What is Ikena Oncology annual cash flow from financing activities?
- What is the all time high annual CFF for Ikena Oncology?
- What is Ikena Oncology annual CFF year-on-year change?
- What is Ikena Oncology quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Ikena Oncology?
- What is Ikena Oncology quarterly CFF year-on-year change?
- What is Ikena Oncology TTM cash flow from financing activities?
- What is the all time high TTM CFF for Ikena Oncology?
- What is Ikena Oncology TTM CFF year-on-year change?
What is Ikena Oncology annual cash flow from financing activities?
The current annual CFF of IKNA is $75.98 M
What is the all time high annual CFF for Ikena Oncology?
Ikena Oncology all-time high annual cash flow from financing activities is $131.74 M
What is Ikena Oncology annual CFF year-on-year change?
Over the past year, IKNA annual cash flow from financing activities has changed by +$74.89 M (+6838.81%)
What is Ikena Oncology quarterly cash flow from financing activities?
The current quarterly CFF of IKNA is $0.00
What is the all time high quarterly CFF for Ikena Oncology?
Ikena Oncology all-time high quarterly cash flow from financing activities is $132.53 M
What is Ikena Oncology quarterly CFF year-on-year change?
Over the past year, IKNA quarterly cash flow from financing activities has changed by -$38.92 M (-100.00%)
What is Ikena Oncology TTM cash flow from financing activities?
The current TTM CFF of IKNA is $60.00 K
What is the all time high TTM CFF for Ikena Oncology?
Ikena Oncology all-time high TTM cash flow from financing activities is $248.69 M
What is Ikena Oncology TTM CFF year-on-year change?
Over the past year, IKNA TTM cash flow from financing activities has changed by -$75.86 M (-99.92%)